With the goal of developing US contrast agents for pancreatic ductal adenocarcinoma (PDAC) imaging, we chose to express a single-chain variable fragment (scFv) targeting the thymocyte differentiation antigen (Thy1/CD90)16. This evidence concerns the gene THY1 and pancreatic ductal adenocarcinoma.